Dr. Sanjay Maraboyina
Claim this profileUniversity of Arkansas for Medical Sciences
Affiliated Hospitals
University Of Arkansas For Medical Sciences
Clinical Trials Sanjay Maraboyina is currently running
Shorter vs Usual Radiation Therapy
for Prostate Cancer
This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period of time. This trial is evaluating if shorter duration radiation prevents cancer from coming back as well as the usual radiation treatment.
Recruiting
2 awards
Phase 3
10 criteria
Stereotactic Radiation + Immunotherapy
for Kidney Cancer
This phase II trial tests whether the addition of radiation to the primary tumor, typically given with stereotactic ablative radiation therapy (SABR), in combination with standard of care immunotherapy improves outcomes in patients with renal cell cancer that is not recommended for surgery and has spread from where it first started (primary site) to other places in the body (metastatic). Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses of radiation over a shorter period and cause less damage to normal tissue. Immunotherapy with monoclonal antibodies, such as nivolumab, ipilimumab, avelumab, and pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Axitinib, cabozantinib, and lenvatinib are in a class of medications called antiangiogenic agents. They work by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving SABR in combination with standard of care immunotherapy may help shrink or stabilize the cancer in patients with renal cell cancer.
Recruiting
1 award
Phase 2
21 criteria
More about Sanjay Maraboyina
Clinical Trial Related
7 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Sanjay Maraboyina has experience with
- Stereotactic Body Radiation Therapy
- Atezolizumab
- Apalutamide
- Degarelix
- Histrelin
- Bicalutamide
Breakdown of trials Sanjay Maraboyina has run
Prostate Cancer
Prostate Adenocarcinoma
Lung Cancer
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sanjay Maraboyina specialize in?
Sanjay Maraboyina focuses on Prostate Cancer and Prostate Adenocarcinoma. In particular, much of their work with Prostate Cancer has involved treating patients, or patients who are undergoing treatment.
Is Sanjay Maraboyina currently recruiting for clinical trials?
Yes, Sanjay Maraboyina is currently recruiting for 2 clinical trials in Little Rock Arkansas. If you're interested in participating, you should apply.
Are there any treatments that Sanjay Maraboyina has studied deeply?
Yes, Sanjay Maraboyina has studied treatments such as Stereotactic Body Radiation Therapy, Atezolizumab, Apalutamide.
What is the best way to schedule an appointment with Sanjay Maraboyina?
Apply for one of the trials that Sanjay Maraboyina is conducting.
What is the office address of Sanjay Maraboyina?
The office of Sanjay Maraboyina is located at: University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205 United States. This is the address for their practice at the University of Arkansas for Medical Sciences.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.